IR@PKUHSC  > 北京大学第一临床医学院  > 肾脏内科
学科主题临床医学
Progression of IgA Nephropathy under Current Therapy Regimen in a Chinese Population
Li, Xiangling1,2,3,4,5; Liu, Youxia1,2,3,4; Lv, Jicheng1,2,3,4; Shi, Sufang1,2,3,4; Liu, Lijun1,2,3,4; Chen, Yuqing1,2,3,4; Zhang, Hong1,2,3,4
刊名CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
2014-03-07
DOI10.2215/CJN.01990213
9期:3页:484-489
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Urology & Nephrology
研究领域[WOS]Urology & Nephrology
关键词[WOS]IMMUNOGLOBULIN-A NEPHROPATHY ; RANDOMIZED CONTROLLED-TRIAL ; GALACTOSE-DEFICIENT IGA1 ; RISK-FACTORS ; DISEASE PROGRESSION ; ALPHA-TOCOPHEROL ; ORAL CALCITRIOL ; RENAL SURVIVAL ; PROTEINURIA ; GLOMERULONEPHRITIS
英文摘要

Background and objectives

Current therapy for IgA nephropathy mainly includes renin-angiotensin system inhibitors and adding steroids for patients with persistent proteinuria. This study aimed to evaluate kidney disease progression and its risk factors in a Chinese cohort under current therapy.

Design, setting, participants, & measurements

Patients with IgA nephropathy followed up for at least 12 months from a prospective database were involved. Renal survival and the relationship between clinical parameters and composite kidney failure events (defined as end stage kidney failure or eGFR halving) were assessed.

Results

Overall, 703 patients between 2003 and 2011 were enrolled in this study, with a mean follow-up time of 45 months. Mean eGFR was 84.0 ml/min per 1.73 m(2), systolic BP was 124 mmHg, and time-averaged mean arterial pressure was 90.0 mmHg. Median proteinuria at baseline was 1.60 g/d, and time-averaged proteinuria was 0.80 g/d. The mean rate of eGFR decline was -3.12 ml/min per 1.73 m(2) per year (95% confidence interval, -19.07 to 11.80), and annual end stage kidney failure rate was 2.3%. Multivariate Cox regression analyses revealed that baseline eGFR (hazard ratio, 0.76 per 10 ml/min per 1.73 m(2); 95% confidence interval, 0.66 to 0.91), proteinuria at 6 months (hazard ratio, 1.53 per g/d; 95% confidence interval, 1.27 to 1.84), and systolic BP control at 6 months (hazard ratio, 1.36 per 10 mmHg; 95% confidence interval, 1.05 to 1.77) were associated with composite kidney failure events. Baseline eGFR (regression coefficient, -0.06; 95% confidence interval, -0.07 to -0.04), time-averaged proteinuria (regression coefficient, -0.21; 95% confidence interval, -0.25 to -0.16), and time-averaged mean arterial pressure (regression coefficient, -0.15; 95% confidence interval, -0.21 to -0.09) were independent predictors of the slope of eGFR by linear regression.

Conclusion

Lower proteinuria and lower BP were associated with slower eGFR decline and lower risk of end stage kidney failure in patients currently being treated for IgA nephropathy.

语种英语
WOS记录号WOS:000332518300011
项目编号81322009 ; 81270795 ; 2012CB517700 ; NCET-12-0011 ; Z12110700100000 (2011-4021-06) ; 81021004
资助机构National Natural Science Foundation (NSF) of China ; Major State Basic Research Development Program of China 973 Program ; Program for New Century Excellent Talents in University from the Ministry of Education of China ; Capital Clinical Research Grant ; NSF for Innovative Research Groups of China
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54051
专题北京大学第一临床医学院_肾脏内科
作者单位1.Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China
2.Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China
3.Peking Univ, Div Renal, Hosp 1, Beijing 100871, Peoples R China
4.Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100871, Peoples R China
5.Weifang Med Coll, Affiliated Hosp, Dept Nephrol, Weifang, Shandong, Peoples R China
推荐引用方式
GB/T 7714
Li, Xiangling,Liu, Youxia,Lv, Jicheng,et al. Progression of IgA Nephropathy under Current Therapy Regimen in a Chinese Population[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,2014,9(3):484-489.
APA Li, Xiangling.,Liu, Youxia.,Lv, Jicheng.,Shi, Sufang.,Liu, Lijun.,...&Zhang, Hong.(2014).Progression of IgA Nephropathy under Current Therapy Regimen in a Chinese Population.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,9(3),484-489.
MLA Li, Xiangling,et al."Progression of IgA Nephropathy under Current Therapy Regimen in a Chinese Population".CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 9.3(2014):484-489.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Xiangling]的文章
[Liu, Youxia]的文章
[Lv, Jicheng]的文章
百度学术
百度学术中相似的文章
[Li, Xiangling]的文章
[Liu, Youxia]的文章
[Lv, Jicheng]的文章
必应学术
必应学术中相似的文章
[Li, Xiangling]的文章
[Liu, Youxia]的文章
[Lv, Jicheng]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。